GlassScriptPhysician profile
Wendy W Lim
NPI 1659425510
$2,377.36
in general payments reported to CMS, 2019-2025
12 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $83.10 · 2021: $22.92 · 2022: $244 · 2023: $515 · 2024: $846 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,713 · Entertainment: $40.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.71 |
| Entertainment | $40.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,540.82 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $248.74 | 2019-2024 | Dailies Total1, Dailies |
| Optos, INC. | $137.20 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $130.01 | 2019-2024 | |
| Tarsus Pharmaceuticals, INC. | $100.20 | 2024 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $65.11 | 2019 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Lkc Technologies, INC. | $27.32 | 2023-2024 | |
| Maculogix, INC. | $27.06 | 2020 | |
| Allergan, INC. | $22.91 | 2022 | |
| Bausch & Lomb Americas INC. | $21.95 | 2024 | Miebo |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.